sglt2 inhibitor vs glp 1 PDF] Effects Of GLP-1 Analogues, DPP-4 Inhibitors And Inhibitors On The Renal System Summary of cardiovascular outcome trials

Introduction With the decline in the birth rate and extension of life expectancy, the composition of the global population is changing dramatically

Adverse events observed at high exposure levels or in small, poorly controlled trials were sometimes taken as definitive evidence against a target

Journal of Experimental Medicine 2010

Key Takeaway: GLP-1 medications are considered qualified medical expenses because they treat a recognized medical condition (obesity or diabetes), allowing you to pay for them using pre-tax dollars from an HSA or FSA

The protocols and the subject information/informed consent forms were reviewed and approved by an independent ethics committee (Ethik-Kommission des Landes Berlin) and by appropriate health authorities according to local regulations